Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TransMedics Group ( (TMDX) ) has provided an announcement.
TransMedics Group, Inc. has appointed Gerardo Hernandez as the new Chief Financial Officer, effective December 2, 2024, succeeding Stephen Gordon. Hernandez brings over 25 years of financial experience across healthcare and consumer sectors, having previously held significant roles at Alnylam Pharmaceuticals and Shire. The company also updated its 2024 financial outlook, projecting substantial revenue growth. This strategic leadership change aims to enhance TransMedics’ operations and expand its market influence in organ transplantation technologies.
See more data about TMDX stock on TipRanks’ Stock Analysis page.
